| Literature DB >> 4070116 |
N Lazebnik, S Noy, R Lazebnik, Y Hezroni, I Amoday, A Aviram.
Abstract
The serum half-life of gentamicin following an intravenous dose was compared between 19 pregnant women (28-34 weeks of pregnancy) with premature rupture of the membranes and 17 non-pregnant women with pelvic inflammatory disease, the groups being age and weight matched. A significant reduction of gentamicin half-life was found in the pregnant group.Entities:
Mesh：
Substances：
Year: 1985 PMID： 4070116 PMCID： PMC2418464 DOI： 10.1136/pgmj.61.721.979
Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401